Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Resolutions at the Annual General Meeting in Viking Supply Ships AB (publ)

At the Annual General Meeting in Viking Supply Ships AB (publ) held on 1 April 2020 in Gothenburg, principally the following was resolved. No dividend was paid for the fiscal year 2019 and the profits were carried forward to the new accounts. The group’s and the company’s income statement for the financial year 1 January–31 December 2019, and the balance sheet as of 31 December 2019 were adopted. The board members and the CEO were discharged from liability for the financial year of 2019. Bengt A. Rem (Chairman), Folke Patriksson (Vice-chairman), Erik Borgen, Håkan Larsson and

Bulletin from Ratos’s AGM 1 April 2020

Ratos’s Annual General Meeting (AGM) was held on 1 April 2020 at Skandiascenen, Cirkus, in Stockholm.The AGM adopted the parent company and the consolidated balance sheets and income statements for the 2019 financial year. The AGM granted the board members and the CEO discharge from liability for the 2019 financial year. Election of Board of Directors and Auditor etc.The AGM followed the Nomination Committee's proposal and decided to appoint six directors, without deputy directors, and to re-elect Board members Per-Olof Söderberg, who was also re-elected as Chairman of the Board, Eva

Immunovia Takes Action During COVID-19 Pandemic and Remains Focused on Launch of IMMray[™] PanCan-d

LUND, SWEDEN – Immunovia AB (publ) (“Immunovia”) today provides an update on the actions that the company is taking to support patients, employees, and public health initiatives in response to the coronavirus (COVID-19) pandemic. Despite these extraordinary times, Immunovia remains focused on the Q3 2020 sales start for the first test for early diagnosis of pancreatic cancer, IMMray™ PanCan-d. The company will continue to monitor the global development of the COVID-19 epidemic closely and enact strategies that adhere to authorities' guidelines in each of the countries where we are active

Total Voting Rights

1 April 2020 15:00 BST     Transparency DirectiveVoting Rights and Capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 March 2020 the issued share capital of AstraZeneca PLC with voting rights is 1,312,225,245 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,312,225,245.The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which

IFS Remote Assistance harnesses merged reality to reimagine service efficiency

IFS Remote Assistance deployed at Munters in six days to ensure safety of field staff while delivering increased efficiency London, April 1, 2020 – IFS , the global enterprise applications company, announces the availability of IFS Remote Assistance™ , a state-of-the-art merged reality (MR) solution that enables field technicians, engineers or customers to share real-life situational context with remote product experts so that hands-on service and repair instructions can be visually demonstrated and acted upon. The solution

FundedByMe announces the result of the rights issue*

FundedByMe Crowdfunding Sweden AB, listed on NGM Nordic SME, today announces that the rights issue, that is 100% guaranteed, is now completed.The rights issue, which the Board decided on March 4, 2020 (through the utilization of the mandate received by the Board at the 2019 Annual General Meeting) with the subscription period March 13, 2020 - March 27, 2020, has added 804,655 Class A shares at a subscription price of SEK 2.20 per A share. This means that the company has received a maximum of SEK 1,770,241 before issue costs (before guarantors), and the remaining part up to SEK 4,944,302

IAR Systems enables secure applications based on NXP’s LPC55S6x Arm Cortex-M33 MCUs

The security development tool C-Trust, an extension to the complete development toolchain IAR Embedded Workbench, now supports LPC55S6x MCUs from NXPStockholm, Sweden—April 1, 2020—IAR Systems, the future-proof supplier of software tools and services for embedded development, announces support in its security tool C-Trust® for the Arm® Cortex®-M33 based LPC55S6x MCUs from NXP® Semiconductors, which will assist companies in easing the implementation of security in their applications. “Collaboration with important partners and carefully listening to our joint customers’ needs are part of

IAR Systems enables secure applications based on NXP’s LPC55S6x Arm Cortex-M33 MCUs

The security development tool C-Trust, an extension to the complete development toolchain IAR Embedded Workbench, now supports LPC55S6x MCUs from NXPUppsala, Sweden—April 1, 2020—IAR Systems, the future-proof supplier of software tools and services for embedded development, announces support in its security tool C-Trust® for the Arm® Cortex®-M33 based LPC55S6x MCUs from NXP® Semiconductors, which will assist companies in easing the implementation of security in their applications. NXP’s LPC55S6x MCUs are dual-core Arm Cortex-M33 MCUs, which leverage the Armv8-M architecture to introduce

Azelio Newsletter, March 2020

Update on Azelio's progress and recent happnings.Partners/Agreements• Azelio initiates collaboration in Oman with an MoU • Azelio signs MoU for energy storage project in Jordan Organization development/progress• Azelio’s installation delivers first electricity in Morocco • Azelio completes an over-subscribed rights Issue of SEK 350 million • Azelio appoints Tine Cato as Sales Strategy Manager • Azelio inaugurates its energy storage in Åmål, Sweden • Azelio holds a well-attended inauguration at Noor in Morocco • Agreement with DNV-GL for verification of its Azelio’s energy

Karo Pharma enters the Swiss market with direct presence by acquiring Hygis SA

Karo Pharma AB (Karo) has today acquired Hygis SA (Hygis), a Swiss distributing company with exclusive distribution rights to Karo’s brands MultiGyn and MultiMam. Hygis operations is limited to the distribution of these brands and by the acquisition Karo gains control over the direct sales of its brands. Karo expects to reach an annual net sales of Euro 1.3 Million related to the two brands. Additionally Karo sees clear synergy opportunities on other brands currently being sold in the Swiss market. “By acquiring Hygis we take an additional step in building up our direct presence in

Amended decision regarding proposed dividend

Nolato AB’s Board of Directors has taken the decision to withdraw the previously announced dividend proposal to the 2020 AGM of SEK 14.50 per share. The decision has been taken despite Nolato’s healthy financial position, and does not signal a change in the company’s dividend policy or future dividend targets. The decision comes in light of the considerable uncertainty resulting from the impact of the COVID-19 pandemic. The Board has chosen to withdraw its dividend proposal to the AGM as a precautionary measure and in order to gain a better overview of the consequences of the pandemic,

BRAbank ASA: BRA-ME - Minutes from Annual General Meeting

Bergen, 1 april 2020The annual general meeting of BRAbank ASA was held on 1 april 2020 at Starvhusgaten 4, Bergen.The proposals on the agenda were adopted.The complete minutes of the annual general meeting is attached to this release and is also available on www.brabank.no. This information is published in accordance with the requirements of the Continuing Obligations of companies admitted to trading on Merkur Market.

CELLCYTE X wins prestigious Red Dot for outstanding design quality

CELLINK has been awarded the Red Dot Award: Product Design 2020 for the design of the live-cell imaging microscopy system CELLCYTE X. This means that CELLINK is one of the winners in the world’s most renowned design competition, recognized as a high achievement of design quality with entries from top companies all over the world.“We are truly honored to get this recognition. It is a quality stamp that shows that we are bringing a design and user-friendliness focus into the market of laboratory equipment, a market that too often has products with an obsolete design-language and a forgotten

Comprend acquires ReportWatch

Digital corporate communications agency Comprend, based in Stockholm and London, has acquired ReportWatch, the brand behind the annual survey and rating of annual reports – Annual Report on Annual Reports.Comprend is the agency that founded Webranking - the global ranking of corporate websites based on stakeholder needs. Webranking and Annual Report on Annual Reports both started in the late 1990s with a mission to help companies improve their corporate communication. Throughout the years, the two rankings have evaluated corporate communication in two of the most important channels – the

SBB sells a portfolio of residential properties to Kuststaden

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) sells a portfolio 545 rental apartments in southern Sweden to Kuststaden. The agreed property value exceeds the most recent external valuation. The properties included in the transaction with Kuststaden comprise a total of 38,900 square meters of residential apartments are sold at an agreed property value of SEK 469.5 million. The apartments are located in three Swedish municipalities: Västervik, Nybro and Vaggeryd. “The deal shows once again that Swedish rent regulated rental properties are very liquid and safe assets. In addition,

Karo Pharma publishes the 2019 annual report

Today, on 1 April 2020, Karo Pharma is publishing its annual report for 2019 on the company’s website, www.karopharma.com. FOR ADDITIONAL INFORMATION, PLEASE CONTACT:Jon Johnsson, CFO, +46 735 078 861, jon.johnsson@karopharma.com ABOUT KARO PHARMAKaro Pharma specialises in the sales and marketing of prescription drugs and over the counter products for everyday healthcare. Karo Pharma is headquartered in Stockholm, Sweden, and quoted on Nasdaq Stockholm Mid Cap. This information is information that Karo Pharma is obliged to make public pursuant to the Swedish Securities Market

Last day of trading with BTA in Idogen

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE.The rights issue in Idogen AB (“Idogen” or the “Company”) has today been registered with the Swedish Companies Registration Office (Sw. Bolagsverket) and paid subscribed shares (BTA) will be replaced by ordinary shares. The last day for trading with BTA is on April 6, 2020 and new shares will be transferred to the respective

Axactor SE annual general meeting

Oslo, April 1st 2020 Axactor SE held its annual general meeting today 1 April 2020. All the matters on the agenda was approved.  After the annual general meeting the board has the following composition Glen Ole Rødland as chair and Brita Eilertsen, Merete Haugli, Lars Erich Nilsen, Kathrine Astrup Fredriksen and Terje Mjøs as board members.  The nomination committee has the following composition: Anne Lise E Gryte and Magnus Tvenge.  The minutes from the meeting is enclosed and available at the company’s website.  About Axactor Axactor Group is a next-generation debt

Hexagon Composites ASA: Notice of Annual General Meeting

The annual general meeting of Hexagon Composites ASA will be held Wednesday 22 April 2020 at the Company's office in Korsegata 4B, Aalesund, Norway. The board of directors does not propose a dividend for 2019. The notice, including agenda for the General Meeting is attached. The notice will be sent to shareholders on 1 April 2020. Due to contagion risk from the coronavirus outbreak, and to ensure accomplishment of the Annual General Meeting in case of new restrictions and guidelines for gathering of people, it is highly recommended to participate in this year’s Annual General

Finnfund invests in improving women's access to critical health care products in East Africa

Finnfund has decided to invest in Kasha , an e-commerce platform improving women’s access to genuine health, hygiene and self-care products in East Africa. The company sells menstrual care products, contraceptives, pharmaceuticals and a range of beauty products via its own platform, accessible through basic phones and a website and delivered to customers confidentially. Kasha aims to be a trusted source of information especially around stigmatised products and operates in close cooperation with selected health partners. Kasha was first founded in 2016 in Rwanda and

The effects of COVID-19 lead to an estimated drop of net sales by 15-20 percent in the first quarter and a lower operating margin. Full year forecast for 2020 is withdrawn.

There is still a high degree of uncertainty regarding both short- and long-term effects of COVID-19, but there has been substantial negative impact on both demand and operations during March. For the first quarter of 2020, Haldex expects sales and operating margins to be significantly lower than was expected in the previously communicated full-year forecast. Given the circumstances, Haldex has withdrawn the full year forecast and at this stage no updated forecast can be submitted.The COVID-19 outbreak has led to lower demand and major disruptions for parts of the business. For the first

COMPANY ANNOUNCEMENT NO 7 2020 - Decisions of General Meeting

Course of Annual General Meeting and Election of Officers of the BoardOn 31 March 2020 the Annual General Meeting in Astralis Group A/S was held. The Annual General Meeting considered the following agenda items. 1. Election of Chairman of the General Meeting. 2. The Board of Directors' (the “Board”) report on the Company's activities during the past financial year. 3. Proposal by the Board to prepare and present Annual Reports in English 4. Adoption of the audited 2019 Annual Report. 5. Proposed transfer of loss as noted in the adopted 2019 Annual Report. 6. Election of

There are no items matching the current filter
There are no more items matching the current filter
Back to top